Innate Pharma SA
NASDAQ:IPHA
Innate Pharma SA
NASDAQ:IPHA
Price:
2.16
USD
-4.85%
Market Cap:
$174.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Innate Pharma SA
NASDAQ:IPHA
|
FR |
|
Praemium Ltd
ASX:PPS
|
AU |
|
Greenkraft Inc
OTC:GKIT
|
US |
Shareholder Yield
Current shareholder yield for 
IPHA is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
IPHA Price
Innate Pharma SA
Innate Pharma SA
Annual Price Range
2.16
52w Low
1.17
52w High
2.535
Price Metrics
| Average Annual Return | -11.11% |
| Standard Deviation of Annual Returns | 31.77% |
| Max Drawdown | -86% |
Shares Statistics
| Market Capitalization | 176m USD |
| Shares Outstanding | 80 950 800 |
| Percentage of Shares Shorted | 0.19% |
IPHA Return Decomposition
Main factors of price return
Main factors of price return
